Jason Condon

Jason Condon has held various roles in the biopharmaceutical industry since 2004. In 2004, they were an Associate Engineer at Bristol-Myers Squibb, where they executed initial upstream commissioning, start-up and validation of a pilot-scale biologics facility that was used to support a commercial manufacturing operation. Jason then moved to Janssen, Pharmaceutical Companies of Johnson and Johnson in 2005, where they first held the role of Scientist, managing a team of more than 10 scientists and engineers toward the completion of an inter-departmental project for an internal J&J client. Jason then held the role of Supervisor, managing 5 direct reports and holding 1:1 meetings and annual performance reviews. In 2013, they moved to Vaccinex, Inc. as Senior Project Manager, CMC, where they were responsible for management of the entire clinical trial drug supply chain including on-time delivery of clinical supplies and relationship management with critical stakeholders. In 2015, they became an Adjunct Assistant Professor at the University of Rochester, designing and implementing an upper level course on Bioprocess Engineering in PowerPoint, conducting lectures on fundamentals of Bioprocess Engineering, and answering student questions. In 2020, they began working as an Independent Consultant, working as a Project Manager and Subject Matter Expert for biologics drug substance manufacturing for two products in early clinical development, and as a CMC Technical Writer authoring Module 3 of an Investigational New Drug (IND) application for a gene therapy product. Currently, they are the Director of Drug Substance Technical Operations at Cue Biopharma.

Jason Condon completed their undergraduate studies at the University of Rochester from 2000 to 2004, earning a Bachelor of Science in both Bioengineering and Biomedical Engineering. Jason then went on to pursue a Master's degree in Biotechnology at the University of Pennsylvania from 2005 to 2007.